Navigation Links
Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic

ENGLEWOOD, Colo., Sept. 21 /PRNewswire/ -- Baxa Corporation, a leading provider of systems for safe fluid handling and delivery in hospital pharmacies, announces the addition of two new international product distributors. These agreements -- with Magallan Pharma Trading Corporation in Colombia and Pentafarma & Co. in The Dominican Republic -- will enable Baxa to extend its global reach and expand product promotion in South America and the Caribbean.

"Global markets offer significant potential for growth in Baxa Corporation's key product lines," says Steve Welch, VP of New Business Development. "These new partnerships expand the visibility of the Baxa brand and give us opportunities for sales growth and market expansion. With their focus on pharmacy efficiency and patient safety, Baxa products offer a unique value in healthcare worldwide."

Baxa Corporation provides distributor training and technical support at its headquarters in Englewood, Colorado. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners in 35 other countries worldwide.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities --

About Magallan Pharma Trading

Magallan is a newly formed company within a group of companies serving the healthcare industry in Colombia. 'Salud Total,' overseeing Magallan, is the third largest health services company in Colombia. Magallan is responsible for location of needed products, Colombian registration with the Health authorities and product distribution.

About Pentafarma CxA

Pentafarma is a pharmaceutical and medical device distributor in the Dominican Republic selling supplies to hospitals in that country. Clients include oncology and gynecological hospitals and surgery centers.


Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157


Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558


Luis Jimenez

Magallan Pharma Trading Corp: 57-12-55-9945


Leida Perez

Pentafarma & Co. CXA:


Fax; 809-563-5143


SOURCE Baxa Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
3. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
4. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
5. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
6. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
7. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
10. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
11. Global Rabies Treatment May be Possible with NanoViricides Drugs
Post Your Comments:
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Competitive Intelligence, ... --> ) has ... Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... most successful and prominent nonprofit healthcare organizations in the country. They have overseen ... various organizations, and helped advance the healthcare industry as a whole through their ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
Breaking Medicine News(10 mins):